| Project/Area Number |
14370528
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Obstetrics and gynecology
|
|---|
| Research Institution | Gifu University |
|---|
Principal Investigator |
FUJIMOTO Jiro Gifu University, University Hospital, Assistant Professor, 医学部附属病院, 講師 (80199372)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
TAMAYA Teruhiko Gifu University, Graduate School of Medicine, Professor, 大学院・医学系研究科, 教授 (70079870)
|
|---|
| Project Period (FY) |
2002 – 2005
|
| Project Status |
Completed (Fiscal Year 2005)
|
| Budget Amount *help |
¥11,900,000 (Direct Cost: ¥11,900,000)
Fiscal Year 2005: ¥1,700,000 (Direct Cost: ¥1,700,000)
Fiscal Year 2004: ¥1,700,000 (Direct Cost: ¥1,700,000)
Fiscal Year 2003: ¥1,600,000 (Direct Cost: ¥1,600,000)
Fiscal Year 2002: ¥6,900,000 (Direct Cost: ¥6,900,000)
|
|---|
| Keywords | gynecological cancers / metastasis / angiogenesis / angiogenic factor / transcription factor / angiogenic inhibitor / tumor dormancy therapy |
|---|
| Research Abstract |
Each gynecological cancer conserves specific expression manners of angiogenic factors and of the angiogenic transcription factor ETS-1 to promote specific secondary spreading. The keys to creating new strategies of anti-angiogenic therapy are : (1) The overexpression of TP linked to ETS-1 in metastatic lymph nodes of uterine cervical cancers ; (2) The signal switching from VEGF to bFGF linked to ETS-1 with dedifferentiation of uterine endometrial cancers ; and (3) The overexpression of VEGF linked to ETS-1 in peritoneal dissemination of ovarian cancers. We are looking forward to proceeding with clinical trials of anti-angiogenic agents in advanced-stage patients and after curative resection for gynecological cancers.
|
